These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 412451)

  • 21. [A new case of gold-induced hepatitis during the treatment of rheumatoid polyarthritis].
    Tebib J; Colson F; Noël E; Bouvier M
    Rev Rhum Mal Osteoartic; 1988; 55(9):705-7. PubMed ID: 3142032
    [No Abstract]   [Full Text] [Related]  

  • 22. Cholestatic liver disease associated with diphenylhydantoin therapy. Possible pathogenic importance of altered bile salt metabolism.
    Campbell CB; McGuffie C; Weedon AP; Powell LW
    Am J Dig Dis; 1977 Mar; 22(3):255-62. PubMed ID: 842535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Jaundice due to nicotinic acid therapy.
    Einstein N; Baker A; Galper J; Wolfe H
    Am J Dig Dis; 1975 Mar; 20(3):282-6. PubMed ID: 1124751
    [No Abstract]   [Full Text] [Related]  

  • 24. Light- and electron-microscopical study of a case of gold salt-induced hepatotoxicity.
    Fleischner GM; Morecki R; Hanaichi T; Hayashi H; Quintana N; Sternlieb I
    Hepatology; 1991 Sep; 14(3):422-5. PubMed ID: 1908434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A preliminary observation of chrysotherapy for rheumatoid arthritis].
    Zhang NZ
    Zhonghua Nei Ke Za Zhi; 1983 Mar; 22(3):149-51. PubMed ID: 6409538
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute renal failure due to gold.
    Robbins G; McIllmurray MB
    Postgrad Med J; 1980 May; 56(655):366-7. PubMed ID: 6777766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gold-induced hepatotoxicity: case report and review of the literature.
    Howrie DL; Gartner JC
    J Rheumatol; 1982; 9(5):727-9. PubMed ID: 6217328
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatonecrosis resulting from parenteral gold therapy in pemphigus vulgaris.
    Rye B; Krusinski PA
    J Am Acad Dermatol; 1993 Jan; 28(1):99-101. PubMed ID: 8425980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gold myokymia syndrome. A rare toxic manifestation of chrysotherapy.
    Caldron PH; Wilbourn AJ; Bravo EE; Mitsumoto H
    Cleve Clin J Med; 1987; 54(3):225-8. PubMed ID: 3111748
    [No Abstract]   [Full Text] [Related]  

  • 30. Postinjection nonvasomotor reactions during chrysotherapy. Constitutional and rheumatic symptoms following injections of gold salts.
    Halla JT; Hardin JG; Linn JE
    Arthritis Rheum; 1977; 20(6):1188-91. PubMed ID: 409414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver dysfunction associated with gold therapy for RA.
    Lewis D; Madhok R; Capell H
    J Rheumatol; 1984 Jun; 11(3):395-6. PubMed ID: 6429329
    [No Abstract]   [Full Text] [Related]  

  • 32. Maintenance chrysotherapy in rheumatoid arthritis: a comparison of 2 dose schedules.
    Griffin AJ; Gibson T; Huston G; Taylor A
    Ann Rheum Dis; 1981 Jun; 40(3):250-3. PubMed ID: 6787995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gold sodium thiomalate for the treatment of rheumatoid arthritis in a patient with hepatitis B.
    Buckley WA; Stump AL; Monger RM; Lookabill SK
    Ann Pharmacother; 2011 Apr; 45(4):e23. PubMed ID: 21467262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J; Davis P; Owen ET
    J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gold induced ulcerative proctitis: report and review of the literature.
    Marcuard SP; Ehrinpreis MN; Fitter WF
    J Rheumatol; 1987 Feb; 14(1):142-4. PubMed ID: 3106630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis.
    Lorber A; Atkins CJ; Chang CC; Lee YB; Starrs J; Bovy RA
    Ann Rheum Dis; 1973 Mar; 32(2):133-9. PubMed ID: 4632661
    [No Abstract]   [Full Text] [Related]  

  • 37. [Continuous chrysotherapy of rheumatoid disease (evaluation of a retrospective study of 42 cases)].
    D'eshougues JR; Delcambre B; Maquerlot M; Defrance D
    Lille Med; 1977; 22(7):430-8. PubMed ID: 412025
    [No Abstract]   [Full Text] [Related]  

  • 38. Chrysotherapy-induced aplastic anemia: a case report.
    Shearer CA; Parker WA
    Am J Hosp Pharm; 1978 Sep; 35(9):1095-9. PubMed ID: 100010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical and morphological study of the liver injury induced by drugs and chemicals.
    Lai MY; Sung JL; Lin WS; How SW; Yu JY; Wang TH; Chen DS
    Taiwan Yi Xue Hui Za Zhi; 1979 Jun; 78(6):525-48. PubMed ID: 385805
    [No Abstract]   [Full Text] [Related]  

  • 40. The influence of cigarette smoking on blood gold distribution during chrysotherapy.
    James DW; Ludvigsen NW; Cleland LG; Milazzo SC
    J Rheumatol; 1982; 9(4):532-5. PubMed ID: 6813469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.